|
Synonyms: HM-12525A | HM12525A | JNJ-64565111 | JNJ64565111 | LAPS-GLP-1/GCG | MK-6024 | MK6024
Compound class:
Peptide
Comment: Efinopegdutide (MK-6024, formerly HM-12525A and JNJ-64565111) is a once-weekly injectable, dual agonist of the GLP-1 and glucagon receptors [3]. Structurally is a conjugate of an oxyntomodulin analogue and the constant region (Fc) of human IgG4, joined via a 10 kDa polyethylene glycol (PEG) linker. The INN record shows that the amino acid sequence of the oxyntomodulin analogue component is HBQGTFTSDYSKYLDEKRAKEFVQWLMNTC-NH2, where B2 is 2-methylalanyl (2-aminoisobutyryl, Aib). An amide bond between E and K cyclises the peptide.
|
Classification ![]() |
|
| Compound class | Peptide |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 10793 | efinopegdutide |
Synonyms ![]() |
| HM-12525A | HM12525A | JNJ-64565111 | JNJ64565111 | LAPS-GLP-1/GCG | MK-6024 | MK6024 |
Database Links ![]() |
|
| CAS Registry No. | 2055640-93-0 (source: WHO INN record) |
| Search PubMed clinical trials | efinopegdutide |
| Search PubMed titles | efinopegdutide |
| Search PubMed titles/abstracts | efinopegdutide |